Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule Breastfeeding

It is a well known fact that breastfeeding is best source of nutrition for infants. Breast milk provides minerals, vitamins and antibodies in most acceptable format when they need it. Nutrition taken by mother passes to breast-milk and same thing applies to medicines taken by mothers. Not all drugs cause problem for baby but some do. Lets analyze if Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule is safe for baby while breastfed.

What is Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule ?


Nitrofurantoin monohydrate/macrocrystals capsules is indicated only for the treatment of acute uncomplicated urinary tract infections (acute cystitis) caused by susceptible strains of Escherichia coli or Staphylococcus saprophyticus. Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses. To reduce the development of drug-resistant bacteria and maintain the effectiveness of nitrofurantoin monohydrate/macrocrystals capsules and other antibacterial drugs, nitrofurantoin monohydrate/macrocrystals capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. Consequently, many patients who are treated with nitrofurantoin monohydrate/macrocrystals capsules are predisposed to persistence or reappearance of bacteriuria. (See CLINICAL STUDIES). Urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy. If persistence or reappearance of bacteriuria occurs after treatment with nitrofurantoin monohydrate/macrocrystals Capsules, other therapeutic agents with broader tissue distribution should be selected. In considering the use of nitrofurantoin monohydrate/macrocrystals capsules, lower eradication rates should be balanced against the increased potential for systemic toxicity and for the development of antimicrobial resistance when agents with broader tissue distribution are utilized.

Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule safe in breastfeeding?

Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule safe for breastfeeding
There are 2 main ingredients of Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule, Nitrofurantoin and Nitrofurantoin. One by one we have analyzed both Nitrofurantoin and Nitrofurantoin for its impact on breastfeeding and based on our analysis we can conclude that Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule is safe to use in breastfeeding. We recommend you to check our analysis of Nitrofurantoin and Nitrofurantoin as below.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers Nitrofurantoin has been detected in human breast milk in trace amounts. Because of the potential for serious adverse reactions from nitrofurantoin in nursing infants under one month of age, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. (See CONTRAINDICATIONS.)

Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule Breastfeeding Analsys


Nitrofurantoin while Breastfeeding

Safe

CAS Number: 67-20-9

Excretion into breast milk is clinically non-significant with no side-effects observed among breastfed infants from treated mothers except rare cases of diarrhea. Do not use while the infant is younger of two weeks of age or suffers of G-6-P dehydrogenase deficiency to avoid likelihood of hemolysis. Be aware of false negative results that may be obtained from febrile infants with bacterial cultures when the mother is on antibiotics. Also, the possibility of developing diarrhea due to bacterial flora imbalance.

Nitrofurantoin while Breastfeeding

Safe

CAS Number: 67-20-9

Excretion into breast milk is clinically non-significant with no side-effects observed among breastfed infants from treated mothers except rare cases of diarrhea. Do not use while the infant is younger of two weeks of age or suffers of G-6-P dehydrogenase deficiency to avoid likelihood of hemolysis. Be aware of false negative results that may be obtained from febrile infants with bacterial cultures when the mother is on antibiotics. Also, the possibility of developing diarrhea due to bacterial flora imbalance.

Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule Breastfeeding Analsys - 2


Nitrofurantoin while Breastfeeding

CAS Number: 67-20-9

Administration of nitrofurantoin directly to infants under 1 month of age and in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency is contraindicated because of potential hemolysis in these infants. However, the time of greatest risk for hemolysis in fullterm newborns without G6PD deficiency might be as short as 8 days after birth.[1] Nitrofurantoin doses in milk are low and it can be used while breastfeeding older infants, but alternate drugs are preferred in mothers of infants under 8 days of age, or infants with G6PD deficiency of any age. Observe infants for possible diarrhea.

Nitrofurantoin while Breastfeeding

CAS Number: 67-20-9

Administration of nitrofurantoin directly to infants under 1 month of age and in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency is contraindicated because of potential hemolysis in these infants. However, the time of greatest risk for hemolysis in fullterm newborns without G6PD deficiency might be as short as 8 days after birth.[1] Nitrofurantoin doses in milk are low and it can be used while breastfeeding older infants, but alternate drugs are preferred in mothers of infants under 8 days of age, or infants with G6PD deficiency of any age. Observe infants for possible diarrhea.


What should I do if already breastfed my kid after using Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule?

Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.


My doctor has prescribed me Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule, what should I do?

Definitely, Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule, will my baby need extra monitoring?

No extra baby monitoring required while mother is using Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule


Who can I talk to if I have questions about usage of Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Monohydrate/macrocrystalline Capsule in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Nitrofurantoin (monohydrate/macrocrystals) Capsule
Nitrofurantion Macrocrystals Capsule
Nitrofurantoin Macrocrystals Capsule
Nitrofurantoin | Nitrofurantion Macrocrystals Capsule
Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin Monohydrate/macrocrystals Capsule
Nitrofurantoin Monohydrate Macrocrystalline | Nitrofurantoin Monohydrate Capsule
Nitrofurantoin Monohydrate/macrocrystals
Nitrofurantion Capsule
Nitrofurantoin Monohydrate/ Macrocrystalline | Nitrofurantoin Capsule
Nitrofurantoin Monohydrate/ Macrocrystalline Capsule
Nitrofurantoin Mono hydrate Capsule
Nitrofurantoin Macrocrystals | Nitrofurantoin Capsule
Nitrofurantoin Suspension
Nitrofurantoin Monohydrate/macrocrystals (monohydrate/macrocrystals)
Macrodantin | Nitrofurantoin Macrocrystals Capsule
Nitrofurantoin Monohydrate/macrocrystalline Capsule